Lütgendorf-Caucig, C.; Wieland, P.; Hug, E.; Flechl, B.; Tubin, S.; Galalae, R.; Georg, P.; Fossati, P.; Mumot, M.; Harrabi, S.;
et al. The Value of PET/CT in Particle Therapy Planning of Various Tumors with SSTR2 Receptor Expression: Comparative Interobserver Study. Cancers 2024, 16, 1877.
https://doi.org/10.3390/cancers16101877
AMA Style
Lütgendorf-Caucig C, Wieland P, Hug E, Flechl B, Tubin S, Galalae R, Georg P, Fossati P, Mumot M, Harrabi S,
et al. The Value of PET/CT in Particle Therapy Planning of Various Tumors with SSTR2 Receptor Expression: Comparative Interobserver Study. Cancers. 2024; 16(10):1877.
https://doi.org/10.3390/cancers16101877
Chicago/Turabian Style
Lütgendorf-Caucig, Carola, Patricia Wieland, Eugen Hug, Birgit Flechl, Slavisa Tubin, Razvan Galalae, Petra Georg, Piero Fossati, Marta Mumot, Semi Harrabi,
and et al. 2024. "The Value of PET/CT in Particle Therapy Planning of Various Tumors with SSTR2 Receptor Expression: Comparative Interobserver Study" Cancers 16, no. 10: 1877.
https://doi.org/10.3390/cancers16101877
APA Style
Lütgendorf-Caucig, C., Wieland, P., Hug, E., Flechl, B., Tubin, S., Galalae, R., Georg, P., Fossati, P., Mumot, M., Harrabi, S., Pradler, I., & Pelak, M. J.
(2024). The Value of PET/CT in Particle Therapy Planning of Various Tumors with SSTR2 Receptor Expression: Comparative Interobserver Study. Cancers, 16(10), 1877.
https://doi.org/10.3390/cancers16101877
